Scientists at St. Jude Children’s Research Hospital have made significant strides in reversing the effects of HNRNPH2 related neurodevelopmental disorder
Nanocarriers are revolutionizing the delivery of sensitive therapeutic agents, particularly peptides and oligonucleotides. By encapsulating these fragile